Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Prostatic Neoplasms 3Herpes Zoster 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 2Papillomavirus Infections 2Neoplasms 2Melanoma 2Lung Neoplasms 2Influenza, Human 2Glioblastoma 2Whooping Cough 1Waldenstrom Macroglobulinemia 1Tetanus 1Spondylitis, Ankylosing 1Psoriasis 1Pancreatic Neoplasms 1Neuroectodermal Tumors, Primitive 1Neoplasms, Glandular and Epithelial 1Multiple Myeloma 1Meningitis 1Medulloblastoma 1Hematologic Neoplasms 1Glioma 1Diphtheria 1Diabetes Mellitus, Insulin-Dependent, 12 1Crohn Disease 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1

Interventions

Carboplatin 235Pemetrexed 214Paclitaxel 160Cisplatin 150pembrolizumab 145Erlotinib Hydrochloride 141Docetaxel 133Gemcitabine 94Bevacizumab 85Nivolumab 72Radiotherapy 62atezolizumab 40Radiosurgery 37Afatinib 37osimertinib 35130-nm albumin-bound paclitaxel 35Cetuximab 34durvalumab 33Ipilimumab 32Gefitinib 31Albumin-Bound Paclitaxel 29Vinorelbine 23Taxes 22Etoposide 20Crizotinib 19Radiation 17Sorafenib 16Cyclophosphamide 16Dexamethasone 15Magnetic Resonance Spectroscopy 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Carcinoma, Non-Small-Cell Lung × Vaccines × Clear all
NCT00654030 2018-04-09

Allogeneic Cellular Vaccine 1650-G for Non-Small Cell Lung Cancer

University of Kentucky

Phase 2 Completed
12 enrolled 7 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡